Medivir initiates Hepatitis C polymerase inhibitor Phase 1a trial
The trial aims to assess the safety, tolerability and pharmacokinetics in healthy volunteers. TMC649128, a nucleoside NS5B polymerase inhibitor with an exciting pre-clinical profile, is indicated for the
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.